347 related articles for article (PubMed ID: 36985442)
1. Food Plant Secondary Metabolites Antiviral Activity and Their Possible Roles in SARS-CoV-2 Treatment: An Overview.
Giordano D; Facchiano A; Carbone V
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985442
[TBL] [Abstract][Full Text] [Related]
2. The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review.
Alipour Z; Zarezadeh S; Ghotbi-Ravandi AA
Planta Med; 2024 Mar; 90(3):172-203. PubMed ID: 37956978
[TBL] [Abstract][Full Text] [Related]
3. An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects.
Jamshidnia M; Sewell RDE; Rafieian-Kopaei M
Curr Pharm Des; 2022; 28(29):2415-2425. PubMed ID: 35899955
[TBL] [Abstract][Full Text] [Related]
4. Antiviral plant-derived natural products to combat RNA viruses: Targets throughout the viral life cycle.
Owen L; Laird K; Shivkumar M
Lett Appl Microbiol; 2022 Sep; 75(3):476-499. PubMed ID: 34953146
[TBL] [Abstract][Full Text] [Related]
5. Natural Products as Potential Agents against SARS-CoV and SARSCoV- 2.
Raimundo E Silva JP; Acevedo CAH; de Souza TA; de Menezes RPB; Sessions ZL; Abreu LS; Cibulski SP; Scotti L; da Silva MS; Muratov EN; Scotti MT; Tavares JF
Curr Med Chem; 2021; 28(27):5498-5526. PubMed ID: 33550959
[TBL] [Abstract][Full Text] [Related]
6. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
[TBL] [Abstract][Full Text] [Related]
7. Screening of Natural Products Inhibitors of SARS-CoV-2 Entry.
González-Maldonado P; Alvarenga N; Burgos-Edwards A; Flores-Giubi ME; Barúa JE; Romero-Rodríguez MC; Soto-Rifo R; Valiente-Echeverría F; Langjahr P; Cantero-González G; Sotelo PH
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268843
[TBL] [Abstract][Full Text] [Related]
8. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review.
Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550
[TBL] [Abstract][Full Text] [Related]
9. Compounds of plants with activity against SARS-CoV-2 targets.
Marmitt DJ; Goettert MI; Rempel C
Expert Rev Clin Pharmacol; 2021 May; 14(5):623-633. PubMed ID: 33706626
[TBL] [Abstract][Full Text] [Related]
10. Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective.
Aggarwal V; Bala E; Kumar P; Raizada P; Singh P; Verma PK
Curr Top Med Chem; 2023; 23(17):1664-1698. PubMed ID: 36974409
[TBL] [Abstract][Full Text] [Related]
11. Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review.
Jantan I; Arshad L; Septama AW; Haque MA; Mohamed-Hussein ZA; Govender NT
Phytother Res; 2023 Mar; 37(3):1036-1056. PubMed ID: 36343627
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Therapeutic Potential of Natural Products.
Low Z; Lani R; Tiong V; Poh C; AbuBakar S; Hassandarvish P
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298539
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
14. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.
Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH
Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466
[TBL] [Abstract][Full Text] [Related]
15. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options.
Sohrab SS; Suhail M; Kamal MA; Azhar EI
Curr Pharm Des; 2021; 27(32):3444-3453. PubMed ID: 33302852
[TBL] [Abstract][Full Text] [Related]
16. Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.
Takahashi JA; Barbosa BVR; Lima MTNS; Cardoso PG; Contigli C; Pimenta LPS
Bioorg Med Chem; 2021 Sep; 46():116366. PubMed ID: 34438338
[TBL] [Abstract][Full Text] [Related]
17. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2.
da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP
Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197
[TBL] [Abstract][Full Text] [Related]
18. Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation.
Zahran EM; Albohy A; Khalil A; Ibrahim AH; Ahmed HA; El-Hossary EM; Bringmann G; Abdelmohsen UR
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339096
[TBL] [Abstract][Full Text] [Related]
19. Targeting natural products against SARS-CoV-2.
Al-Harrasi A; Behl T; Upadhyay T; Chigurupati S; Bhatt S; Sehgal A; Bhatia S; Singh S; Sharma N; Vijayabalan S; Palanimuthu VR; Das S; Kaur R; Aleya L; Bungau S
Environ Sci Pollut Res Int; 2022 Jun; 29(28):42404-42432. PubMed ID: 35362883
[TBL] [Abstract][Full Text] [Related]
20. In silico approach of secondary metabolites from Brazilian herbal medicines to search for potential drugs against SARS-CoV-2.
Amparo TR; Seibert JB; Almeida TC; Costa FSF; Silveira BM; da Silva GN; Dos Santos ODH; de Souza GHB
Phytother Res; 2021 Aug; 35(8):4297-4308. PubMed ID: 33797123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
